Hedge funder Bill Ackman announced the sale of a portion of Pershing Square's PSHZF stake in Universal Music Group UNVGY UMGNF Thursday, continuing his recent financial moves betting on future investments.
Hedge fund manager Bill Ackman said his Pershing Square firm would reduce its stake in the world's largest music company.
NBC Universal has unveiled a $3bn extension of its Olympics deal, ensuring the Summer and Winter Games remain on NBC and its Peacock streaming service in the US until 2036.
Universal Electronics Inc. is poised for growth due to the AI and IoT industry boom, with significant demand for its control and sensor technology solutions. UEIC is streamlining operations in Mexico, China, and Vietnam, which could enhance free cash flow and net income growth. The stock repurchase program and partnerships with industry giants like Samsung and Sony bolster the investment case, making UEIC a buy.
Universal Health Services (UHS) has shown consistent EPS growth, up 11% annually. We note recent stock de-rating over Medicaid cut concerns. UHS operates 419 hospitals, with a balanced revenue mix from Acute Care and Behavioral Health, and significant exposure to Medicaid at 25% of total revenue. Despite excellent Q4 results and moderating nursing costs, UHS stock fell due to fears of imminent Medicaid cuts, which are politically contentious and uncertain.
Universal Music Group's Q4 earnings surpassed expectations, but growth remains below company's targets, with volatile profitability. The gap between UMG and Spotify's growth narrowed in Q4, but remains significant, highlighting Spotify's stronger position in the industry. New multi-year agreements with Spotify and other platforms offer potential for improved monetization and growth in 2025.
Universal Health Realty Income Trust is a healthcare REIT focused on medical office buildings and acute care hospitals. The company's portfolio was stable in 2024, with FFO growth driven by lower operating expenses and higher revenues, which helped offset rising interest costs. FFO growth should continue in 2025, with the REIT benefitting from lease escalators and Fed rate cuts.
UHS' fourth-quarter earnings benefit from rising admissions and patient days. Higher expenses partially offset the positives.
Hospital operator Universal Health Services beat fourth-quarter profit estimates on Wednesday, driven by robust demand for medical care that required hospital stays.
UHS' fourth-quarter earnings are likely to have benefited from growing admissions and patient days.
OLED reports top-line growth year over year, driven by growing traction in the IT, automotive, smartphone and TV end markets.
Cidara Therapeutics is leveraging its Cloudbreak platform to develop CD388 for universal influenza prophylaxis. Fortunately, they recently enrolled 5,000 subjects in its Phase 2b trial to assess CD388's safety and efficacy. CD388 inhibits viral replication and activates the immune response, and its mechanism of action actually received the FDA's Fast Track designation.